Team – Lumio Capital

Our Team

Founder & CEO

Founder of Lumio Capital, an investment platform driving high-impact ventures in healthcare and education across emerging markets.
Spearheaded the creation of ASA Medical Group, the first integrated private healthcare platform in the Balkan region.
Formerly CEO of Amanat Holdings, a Dubai-listed investment firm managing c. USD 1 billion, delivering 28-fold profit growth and USD 2 billion in executed transactions.
Recognised among Forbes Middle East Top 50 Healthcare Leaders, Top 100 Executives by Arabian Business, Young Arab Leaders, and Young Presidents’ Organization (YPO).
Holds an MD and BSc from the American University of Beirut, an MBA from Cornell University, and a Research Fellowship from Harvard Medical School.

Managing Partner

With nearly two decades of experience across private equity, investment banking, and asset management, Hussein has built a track record of originating, structuring, and exiting complex transactions across healthcare, fintech, real estate, manufaturing, retail, and food & beverage sectors.
Hussein’s latest role was CIO at Audacia Capital, and has also served in senior roles at Qatar First Bank (Private Equity) and Audi Capital (Innvestment Banking), where he led end/to/end M&A processes, valuation strategy, and investment committee advisory across transactions exceeding hundreds of millions of dollars.
He holds an Executive MBA from London Business School and BA in Accounting & Finance from the American University of Beirut.

Executive-in-Residence (COO)

Group Chief Operating Officer at ASA Medical Group, leading operational and strategic development of an integrated hospital and outpatient healthcare network.
International healthcare expert with extensive experience in hospital operations, JCI accreditation and international patient safety systems implementation, healthcare digital transformation, operational policies, and hospital governance frameworks. Previously served as Chief Quality Officer at American Hospital Tbilisi. Certified Professional in Healthcare Quality (CPHQ).
Healthcare systems expert and PhD candidate researching digital healthcare strategies, with academic involvement as a lecturer in healthcare information systems, digital health, and medical bioinformatics, contributing to the development of modern healthcare management and innovation practices.

Executive-in-Residence (CFO)

Strategic CFO & Board-Level Advisor
Accomplished Chief Financial Officer with over two decades of experience guiding organizations through financial transformation, complex restructuring, and sustainable growth across the Middle East and the United States.
Driving Turnarounds & Value Creation
Recognized for leading high-impact restructuring and acquisition initiatives, including the successful turnaround of a major hospital, delivering improved profitability, operational efficiency, and enhanced patient satisfaction.
Capital Strategy & Business Expansion
Extensive expertise in financial strategy, feasibility studies, mergers & acquisitions, and capital planning—successfully securing over $200 million in funding to support major institutional expansions and long-term growth.
Global Corporate & Healthcare Leadership
Former senior finance executive at a leading academic medical center and a Fortune 500 multinational corporation, bringing deep experience in financial governance, operational optimization, and executive decision support.

Senior Advisor – Healthcare

Dr. Jamil R. Dibu is a physician executive and strategic healthcare leader based in Abu Dhabi, with over a decade of experience building and scaling clinical programs at Cleveland Clinic Abu Dhabi. He founded the UAE’s first dedicated Neurocritical Care unit, led hospital-wide operational transformation including a 75% ICU capacity expansion during COVID-19, and chaired the national committee that reformed the UAE’s brain death legislation, directly enabling the country’s organ transplantation program. He has driven more than USD 3 million in annual cost savings through supply chain optimization and process redesign.
Dr. Dibu currently serves on the Board of Directors of the Neurocritical Care Society (U.S.) and as President of its MENA Chapter. He is a Clinical Professor of Neurology at Case Western Reserve University School of Medicine and a Scientific Advisor to the Maroon Research Institute, where he provides clinical oversight across brain health, longevity science, and health-tech ventures.
He holds an MD from the American University of Beirut, a Global Executive MBA from INSEAD, and is board-certified in Neurology, Neurocritical Care, and Lifestyle Medicine.

Senior Advisor – Education

Emal Dusst is a global education executive and investor with deep experience building and scaling education and workforce companies. He serves as Managing Director and Head of ETS Capital, where he oversees a portfolio of 15+ global education companies.
Prior to ETS Capital, Emal was a senior investment professional at Sterling Partners. He also served as Chief Strategy Officer & Head of M&A at Laureate Education (NASDAQ: LAUR), then the world’s largest degree-granting higher education network with over one million students across 29 countries, and helped with the founding of Cintana Education.
Emal has served on the boards of numerous leading education companies, including Coursera (NASDAQ: COUR), the world’s largest online learning platform; Lecturio (Germany); Escape Studios (UK); HCI (Australia); Leverage Edu (India); Memorang AI (US); and Universidad Latina de Costa Rica.
He is a member of YPO and a Term Member of the Council on Foreign Relations. Emal holds a B.A. in Economics with a minor in German from UCLA and an MBA from the Kellogg School of Management at Northwestern University.